Prognostic Value of Pretreatment Plasma C-Reactive Protein in Patients with Early-Stage Breast Cancer.

Høgni Hammershaimb Andersen Stig Egil Bojesen Julia Sidenius Johansen Bent Ejlertsen Tobias Berg Malgorzata Tuxen Kasper Madsen Hella Danø Henrik Flyger Maj-Britt Jensen Dorte Lisbet Nielsen

Published in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2024)

CRP measures before treatment might be used to individualize follow-up of patients with early-stage breast cancer.

Keyphrases

early stage
sentinel lymph node
young adults
neoadjuvant chemotherapy
replacement therapy
smoking cessation